Languages
Pages
Legal
Explore all categories to find your favorite topic
1. YRH: Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018 Overview, Size, Share, Analysis, Technology Developments,…
YRH: Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018 Overview, Size, Share, Analysis, Technology Developments,…
E 5 w p d a N a C o c J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 5 , N O . 7 , 2 0 1 2 © 2 0 1 2 B Y T H E A M E R I C A N C O L L E G E O F…
From STEMIs to Stents: Updates in PCI practice Arnold Seto MD MPA Assistant Clinical Professor UC-Irvine and Long Beach VA Director of Interventional Cardiology Research…
Patient Information Guide Everolimus Eluting Coronary Stent System 33 Coronary Artery Disease CAD ........................5 Your Heart ........................................................5…
Drug-Eluting Coronary-Artery Stentsreview article T h e n e w e ngl a nd j o u r na l o f m e dic i n e n engl j med 368;3 nejm.org january 17, 2013254 Drug Therapy Drug-Eluting
the bmj BMJ 2015101h13 doi1 02006bmjh13 RESEARCH 1 open access 1Department Ferrarotto Hospital Catania Italy 2Department of General Surgery and Medical Surgical Specialties…
8/14/2019 Drug Eluting Stents as an Alternative to Traditional Stenting in the Treatment of Coronary Artery Disease Cypher S 1/23Page 1 of 22TITLE: Drug-Eluding Stents as…
“Randomized Comparison between Sirolimus (Cypher)/Sirolimus-analogous (Xience; Promus) vs. Paclitaxel (Taxus vs.Costar) Eluting Stents in Coronary Lesions: a Single Center…
RRC_art 9.inddORIGINAL ARTICLE The activity of the Interventional Cardiology Centers in Romania: a 2015 overview Marin Postu1, Lucian Predescu1,2, Stefan Mot3 Contact address:
Regulating Innovation with Uncertain Quality: Information Risk and Access in Medical Devices Matthew Grennan∗ University of Pennsylvania The Wharton School and NBER grennan@whartonupennedu…
1 Ten-Year Outcomes of Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease Duk-Woo Park, MD, Jung-Min Ahn, MD, Sung-Cheol Yun, PhD, Yong-Hoon…
What is the position of NOACs in acute coronary syndromes secondary prevention? Ron Peters Academic Medical Center Amsterdam the Netherlands Part 1. Coronary disease no other…
STATE-OF-THE-ART PAPER Selection of Coronary Stents Antonio Colombo MD FACC* Goran Stankovic MD* Jeffrey W Moses MD FACC† Milan Italy and New York New York In clinical…
Heart Disease in Diabetes Robin Goland, MD Case #1 • 35yo Chinese male w PMH only significant for one episode of pancreatitis 10+ yrs ago resulting in transient insulin-…
Subscription 0080: 2009 DLMann all rights reserved Systematic Innovation e-zine Issue 85 April 2009 In this month’s issue: Article – Case Studies In TRIZ: Stent Evolution…
Coronary Stents in the Management of Coronary Artery Disease Review of Firs00t 1 Stents S C Ng, FSCAP, Chen Sawatt, SRN, L K Foo, SRN, 0 Hitam, ASMLT, P G Khor, ASMLT, Y…
__________ (acronym) TrialPrevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents Prevention of Premature Discontinuation
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention Stents ,adjunctive devices and antithrombotics…
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Michael Maeng, Klaus Rasmussen,…